eligible for SC-12 · confidence ≥ 70%

Patients needing attention

Synthetic demo data

patients · eligible for SC-12 · confidence ≥ 70%

Create intervention

Most common reason

GI intolerance

Most effective previous action

GI-04

Nutritional protocol

Estimated addressable population

eligible for GI-04, confidence ≥ 70%

Predicted persistence gain

+17%

LLIFE OS insight · why this cohort goes where it goes

grounded · add an LLM key for prose

eligible for SC-12 · confidence ≥ 70%: 18 patients, mean day 135. 39% have deteriorating tolerance, 94% unstable GI, 100% carry ≥60% discontinuation risk; mean GI 68, adherence 54%. Dominant clusters: EC-03 56%, LT 44%.

Shared biology: Low microbial diversity 78%, Low butyrate capacity 72%, FUT2 non-secretor 67%, Baseline state S14 56%, Cluster EC-03 (high response / high intolerance) 56%, Adherence < 60% 56%, IL6 high-expression variant 44%. Dietary detractors: fat in 94%, histamine in 67%, lactose in 67%.

What worked: GI-04 improved 50% of 4.

No learned rules apply yet; run learning after the first campaign results.

Patient	Day	Baseline	GI	Tolerance	GI score	Discontinuation	Cluster
P-03067	150	S14	Unstable	Deteriorating	72	96%	EC-03
P-03078	139	S14	Unstable	Unstable	71	96%	EC-03
P-03177	140	S10	Unstable	Stable	81	96%	LT
P-03375	139	S14	Unstable	Deteriorating	71	96%	EC-03
P-03427	107	S14	Unstable	Favorable	68	96%	EC-03
P-03488	146	S14	Unstable	Improving	76	96%	EC-03
P-03345	140	S14	Unstable	Stable	69	95%	EC-03
P-03230	149	S09	Unstable	Improving	73	94%	EC-03
P-03459	145	S14	Improving	Improving	56	88%	EC-03
P-03034	138	S14	Unstable	Stable	78	85%	EC-03
P-03153	143	S08	Unstable	Deteriorating	67	80%	LT
P-03473	116	S01	Unstable	Deteriorating	61	79%	LT
P-03475	120	S14	Unstable	Deteriorating	68	78%	LT
P-03253	147	S15	Unstable	Stable	69	75%	LT
P-03361	150	S14	Unstable	Improving	63	75%	EC-03
P-03303	128	S16	Unstable	Stable	61	71%	LT
P-03273	119	S15	Unstable	Deteriorating	58	68%	LT
P-03227	121	S05	Unstable	Deteriorating	62	62%	LT